Ligand validation:7CL5

OGA: N-OXALYLGLYCINE

OGA is a Ligand Of Interest in 7CL5 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7CL5_OGA_C_302	87%	21%	0.114	0.987	1.37	1.94	2	2	0	0	100%	1
7CL5_OGA_B_302	86%	27%	0.112	0.98	1.29	1.64	1	2	0	0	100%	1
7CL5_OGA_E_302	82%	28%	0.126	0.981	1.53	1.38	3	1	1	0	100%	1
7CL5_OGA_D_302	80%	17%	0.136	0.987	1.83	1.8	2	2	0	0	100%	1
7CL5_OGA_F_302	78%	27%	0.129	0.972	1.4	1.56	3	2	0	0	100%	1
7CL5_OGA_A_302	73%	23%	0.148	0.975	1.48	1.69	2	2	0	0	100%	1
7CL4_OGA_E_302	85%	28%	0.106	0.972	1.42	1.46	1	2	0	0	100%	1
7CL6_OGA_D_302	84%	34%	0.12	0.983	1.04	1.57	-	1	0	0	100%	1
4GJY_OGA_A_502	99%	25%	0.056	0.993	2.38	0.72	2	-	0	0	100%	1
3MS5_OGA_A_390	99%	26%	0.048	0.984	1.22	1.76	1	3	0	0	100%	1
5A1F_OGA_A_1756	99%	17%	0.054	0.985	2.18	1.44	2	2	0	0	100%	1
6F4T_OGA_A_502	98%	14%	0.053	0.979	2.26	1.62	4	2	0	0	100%	1
6F4R_OGA_A_502	98%	20%	0.062	0.984	1.98	1.4	1	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.